Status:
TERMINATED
Efficient Study of ACULAR in Inhibiting Proliferative Retinopathy in Prematurity
Lead Sponsor:
University of South Alabama
Conditions:
Retinopathy of Prematurity
Retinal Detachment
Eligibility:
All Genders
10-15 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to test whether ACULAR, a nonsteroidal anti-inflammatory eye drop medication, can prevent the development of retinopathy of prematurity (ROP) and/ or decrease its severity...
Detailed Description
Each year ROP affects an estimated 14,000-16,000 premature, low birth weight infants in the United States and thousands more worldwide, making it a leading cause of vision loss in children. Of these c...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- All preterm infants of gestational age less or equal to 28 weeks completed gestational age and 10 to 15 days of postnatal age admitted to our regional NICU
Exclusion
Key Trial Info
Start Date :
November 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2008
Estimated Enrollment :
83 Patients enrolled
Trial Details
Trial ID
NCT00634972
Start Date
November 1 2005
End Date
August 1 2008
Last Update
December 8 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Division of Neonatology, Children's & Women's Hospital, University of South Alabama
Mobile, Alabama, United States, 36604-3391